Genetic adjuvants for DNA vaccines (Q34189226)

31 July 2017

1 reference

title

Genetic adjuvants for DNA vaccines (English)

1 reference

Jean-Pierre Y Scheerlinck

31 July 2017

author

series ordinal

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

31 July 2017

number of pages

10

1 reference

inferred from page(s)

published in

Vaccine

1 reference

31 July 2017

volume

19

1 reference

31 July 2017

issue

17-19

1 reference

31 July 2017

page(s)

2647-2656

1 reference

Direct gene transfer into mouse muscle in vivo

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Genetic immunization is a simple method for eliciting an immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

DNA vaccination strategies against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Immunization of animals: from DNA to the dinner plate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Genetic immunization with lung-targeting macroaggregated polyethyleneimine-albumin conjugates elicits combined systemic and mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Immunostimulatory bacterial DNA sequences activate dendritic cells and promote priming and differentiation of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Modulating the immune response to genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Polynucleotide vaccines in animals: enhancing and modulating responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

IL-6 induces long-term protective immunity against a lethal challenge of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Immunomodulation by mucosal gene transfer using TGF-beta DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Potentiation of antigen-specific, Th1 immune responses by multiple DNA vaccination with an ovalbumin/interferon-gamma hybrid construct

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

The effect of interferon-Î³ on genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-gamma, IL-12, or IL-18 gene adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Coimmunization with IFN-gamma or IL-2, but not IL-13 or IL-4 cDNA can enhance Th1-type DNA vaccine-induced immune responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Intranasal administration of human immunodeficiency virus type-1 (HIV-1) DNA vaccine with interleukin-2 expression plasmid enhances cell-mediated immunity against HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: implication for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Coadministration of IL-12 or IL-10 expression cassettes drives immune responses toward a Th1 phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Modulation of virus-induced delayed-type hypersensitivity by plasmid DNA encoding the cytokine interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Vaccination with an ovalbumin/interleukin-4 fusion DNA efficiently induces Th2 cell-mediated immune responses in an ovalbumin-specific manner

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Coadministration of DNA Encoding Interleukin-6 and Hemagglutinin Confers Protection from Influenza Virus Challenge in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

HIV-1 DNA vaccines and chemokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

The immunotargeting approach to adjuvant-independent subunit vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

Site-directed immune responses in DNA vaccines encoding ligand-antigen fusions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900495-3

7 January 2021

10.1016/S0264-410X(00)00495-3

Identifiers

DOI

1 reference

31 July 2017

1 reference